Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists..
Metabolism. 66, 64-68.
(2017). Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system..
Med Hypotheses. 102, 33-36.
(2017). Obesity and the nervous system: more questions..
Lancet Neurol. 16(10), 772-773.
(2017). Periostin and sclerostin levels in juvenile Paget's disease..
Clin Cases Miner Bone Metab. 14(2), 269-271.
(2017).
(2017). Adiponectin and vitamin D-binding protein are independently associated at birth in both mothers and neonates..
Endocrine. 59(1), 164-174.
(2018). Comment on "Therapeutic Application of an Extract of Ameliorates the Development of Allergic Airway Disease"..
J Immunol. 200(9), 3027.
(2018). Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence..
Am J Gastroenterol. 113(11), 1723-1724.
(2018). Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence..
Helicobacter. 23(6), e12534.
(2018). infection and esophageal adenocarcinoma: a review and a personal view..
Ann Gastroenterol. 31(1), 8-13.
(2018). Irisin in metabolic diseases..
Endocrine. 59(2), 260-274.
(2018). Juvenile Paget disease..
Metabolism. 80, 15-26.
(2018). Mild leukopenia following denosumab treatment in a woman with postmenopausal osteoporosis..
Endocrine. 62(2), 487-489.
(2018). Multiple Bidirectionality Brain-Gut Interactions in Patients With Inflammatory Bowel Disease..
Gastroenterology. 155(5), 1651-1652.
(2018). Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?.
Calcif Tissue Int. 103(1), 107-108.
(2018). Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment..
Hormones (Athens). 17(4), 573-579.
(2018). Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?.
Hepatology. 68(1), 389.
(2018). Outliers of bone metabolic diseases..
Metabolism. 80, 1-4.
(2018). Pharmacotherapy of type 2 diabetes: An update..
Metabolism. 78, 13-42.
(2018). Potential Impact of Active Helicobacter pylori Infection with or without Concomitant Metabolic Syndrome on Colorectal Cancer Invasion and Mortality..
Isr Med Assoc J. 20(11), 725-726.
(2018). Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology..
Dig Dis Sci. 63(4), 1087-1088.
(2018). A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration..
Neurochem Int. 113, 137-151.
(2018). Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis..
Metabolism. 87, 18-24.
(2018). Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?.
Helicobacter. 23(1),
(2018). Sarcopenic obesity..
Hormones (Athens). 17(3), 321-331.
(2018).